Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D R, Citerone"'
Autor:
S. Rayet, S. Bullman, Jean-Louis Montastruc, Olivier Rascol, C. Brefel, Claire Thalamas, K Fitzpatrick, A. Lopez-Gil, D. R. Citerone, Anne C. Taylor
Publikováno v:
British Journal of Clinical Pharmacology. 45:412-415
Aims Ropinirole is a specific non-ergoline dopamine D2-receptor agonist with antiparkinsonian properties.The pharmacokinetic parameters of ropinirole taken in the fasted condition were compared with those when it was co-administered with food. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8628d4666763ec81c7e52a12ef5b94c7
https://doi.org/10.1046/j.1365-2125.1998.t01-1-00704.x
https://doi.org/10.1046/j.1365-2125.1998.t01-1-00704.x
Autor:
P, Zia-Amirhosseini, R Z, Harris, H C, Cowley, J W, Valle, D R, Citerone, V K, Boppana, H, Scarffe, P, Watson, C B, Davis
Publikováno v:
Pharmaceutical research. 17(4)
To describe the pharmacokinetics of SKF 107647, a synthetic hematoregulatory peptide, in healthy volunteers and in patients with adenocarcinoma.SKF 107647 pharmacokinetics were evaluated in 2 dose-escalation studies. Volunteers received SKF 107647 as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02c21a384f553a54b568780b082ffa09
https://pubmed.ncbi.nlm.nih.gov/10870980
https://pubmed.ncbi.nlm.nih.gov/10870980
Autor:
J, Hubble, W C, Koller, P, Atchison, A C, Taylor, D R, Citerone, B D, Zussman, C J, Friedman, N, Hawker
Publikováno v:
Journal of clinical pharmacology. 40(6)
The objectives of this study were to measure the pharmacokinetics of ropinirole at steady state when the drug is used as an adjunct to L-dopa and evaluate the long-term tolerability of ropinirole in this indication. Twenty-four patients who were taki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7ff3f65bd72ae1d49426827e285f228
https://pubmed.ncbi.nlm.nih.gov/10868315
https://pubmed.ncbi.nlm.nih.gov/10868315
Autor:
D R, Brocks, M I, Freed, D E, Martin, T S, Sellers, N, Mehdi, D R, Citerone, V, Boppana, B, Levitt, B E, Davies, J, Nemunaitis, D K, Jorkasky
Publikováno v:
Pharmaceutical research. 13(5)
To study the pharmacokinetics of SKF 107647, a novel hematoregulatory agent, in rats, dogs, and patients with non-lymphoid solid tumor malignancy.Sprague Dawley rats and beagle dogs (n = 6 each; 3 M, 3 F) were given 25 mg/kg of SKF 107467 as an iv bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dde7d4890eb0764932712d85e904910f
https://pubmed.ncbi.nlm.nih.gov/8860439
https://pubmed.ncbi.nlm.nih.gov/8860439